(September 2, 2015, 1:56 PM EDT) -- ALEXANDRIA, Va. — After deliberating for 2-1/2 hours, a Virginia federal jury on Sept. 1 returned a defense verdict in a two-plaintiff Cymbalta withdrawal trial, finding that defendant Eli Lilly and Co. did not fail to provide an adequate warning to either prescribing plaintiff’s physician (Gilda Hagan-Brown v. Eli Lilly and Company, No. 14-1614, E.D. Va., Alexandria Div.)....